top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001
Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001
Pubbl/distr/stampa Washington : , : U.S. Government Printing Office, , 2001
Descrizione fisica 1 online resource (iii, 191 pages) : illustrations
Soggetto topico Drugs - Inspection - United States
Drug adulteration - Government policy - United States
Pharmaceutical industry - United States - Quality control
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Continuing concerns over imported pharmaceuticals
Record Nr. UNINA-9910708356803321
Washington : , : U.S. Government Printing Office, , 2001
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Counterfeit bulk drugs : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000
Counterfeit bulk drugs : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000
Pubbl/distr/stampa Washington : , : U.S. Government Printing Office, , 2000
Descrizione fisica 1 online resource (iii, 423 pages) : illustrations
Soggetto topico Drugs - Inspection - United States
Drugs - Standards - United States
Drug adulteration - Government policy - United States
Pharmaceutical industry - United States - Quality control
Product counterfeiting - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Counterfeit bulk drugs
Record Nr. UNINA-9910706954803321
Washington : , : U.S. Government Printing Office, , 2000
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Guidance for industry [[electronic resource] ] : Q3B(R2) impurities in new drug products
Guidance for industry [[electronic resource] ] : Q3B(R2) impurities in new drug products
Pubbl/distr/stampa Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, , [2006]
Descrizione fisica 8 pages : digital, PDF file
Soggetto topico Drug development - Government policy - United States
Drug adulteration - Government policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Guidance for industry
Record Nr. UNINA-9910698987503321
Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, , [2006]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Guidance for industry [[electronic resource] ] : ANDAs, impurities in drug products
Guidance for industry [[electronic resource] ] : ANDAs, impurities in drug products
Pubbl/distr/stampa Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, , [2005]
Descrizione fisica 1 online resource (8 pages) : chart
Soggetto topico Drug adulteration - Government policy - United States
Drug approval - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Guidance for industry
Record Nr. UNINA-9910699286903321
Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, , [2005]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui